Skip to main content

Rafael Simó Canonge

Institutions of which they are part

Head of group
Diabetes and Metabolism
Vall Hebron Institut de Recerca

Rafael Simó Canonge

Institutions of which they are part

Head of group
Diabetes and Metabolism
Vall Hebron Institut de Recerca

Projects

Identificación mediante análisis proteómico del humor vítreo de nuevas dianas terapéuticas en la retinopatía diabética proliferativa y en el edema macular diabético

IP: Rafael Simó Canonge
Collaborators: -
Funding agency: Fundación para la Diabetes
Funding: 39942
Reference: BRM2006-01
Duration: 01/01/2007 - 31/12/2008

Mediadores patogénicos del edema macular diabético: exploración de nuevos candidatos mediante análisis proteómico en humor vítreo y cultivos celulares

IP: Rafael Simó Canonge
Collaborators: -
Funding agency: Novo Nordisk Pharma SA
Funding: 6000
Reference: NORDISK/1/2006
Duration: 30/05/2006 - 31/12/2007

Mediadores patogénicos del edema macular diabético: exploración de nuevos candidatos mediante análisis proteómico en humor vítreo y estudios de permeabilidad en cultivos celulares

IP: Rafael Simó Canonge
Collaborators: -
Funding agency: Instituto de Salud Carlos III
Funding: 0.0001
Reference: PI060356
Duration: 01/01/2007 - 30/09/2009

Mediadores patogénicos del edema macular diabético: exploración de nuevos candidatos mediante análisis proteómico en humor vítrico y cultivos celulares

IP: Rafael Simó Canonge
Collaborators: Àlex Fonollosa Calduch, Cristina Hernández Pascual, Monica Higuera Urbano
Funding agency: Ministerio Ciencia, Innovación y Universidades
Funding: 150766
Reference: SAF2006-05284
Duration: 01/10/2006 - 30/09/2009

Ministerio de Ciencia

Related news

The families of the professionals had the opportunity to visit the facilities and discover how we work at the institution.

The document provides recommendations for identifying people who are candidates for these treatments and for guiding their implementation and follow-up in clinical practice.

The publications update the pharmacological management guideline for obesity and its complications and present the first European comprehensive management guideline for patients with obesity treated with medications.

Related professionals

Lidia Estepa Hombrados

Lidia Estepa Hombrados

Postdoctoral researcher
Pneumology
Read more
Sergi Torramadé Moix

Sergi Torramadé Moix

Postdoctoral researcher
Transfusional Medicine
Read more
Sara Palacin i Bonson

Sara Palacin i Bonson

Research technician
Neurodegenerative Diseases
Read more
Frederic Pons Pellicer

Frederic Pons Pellicer

Administration and Management
Nephrology and kidney transplantation
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.